Group Action Lawyers
Latest News & Updates

February 14, 2018
Medtronic recalls disposable diabetes infusion sets over risk of causing hypoglycemia

Medical device manufacturer Medtronic Plc is recalling disposable diabetes infusion sets as a possible defect may trigger excessive doses of insulin to the diabetic user, putting them at risk of hypoglycemia.

The recall reportedly affects insulin infusion sets distributed all over the world.

The device, connected to an insulin pump, features thin plastic tubing with a needle or cannula at the end to carry insulin into the body when needed. However, apparently, “one in every two million” sets may contain a “complication”.
Continue Reading…

pelvic mesh inquiry vaginal mesh implants concerns
February 12, 2018
NICE calls for U.K. surgery ban on vaginal mesh implants

The infamous mesh implants that’s sewn into vagina walls which has reportedly caused multiple injuries and excruciating pain for many women may now be finally banned for good in the U.K.

Those women who had the ‘minor’ routine surgery to help treat organ prolapses and mild incontinence, but then went on to suffer serious and painful complications has prompted the U.K.’s National Institute for Health and Care Excellence (NICE) to recommend that the implants shouldn’t be used in treatment any more at all, only for research.

This is a change to previous NICE guidelines that were more about taking extreme precautions when using the mesh devices.
Continue Reading…

liver disease drug warning
February 09, 2018
Hospitals and Doctors warned over using Intercept Pharmaceuticals liver disease drug

Regulators have issued Doctors and Hospitals with a warning over Intercept Pharmaceuticals liver disease drug after 19 people have reportedly died after taking too much of it.

Regulators also noted 11 cases of serious liver injury after taking the drug as well.

The warning prompted the company’s shares to reportedly plummet down by 24.9%, to $73.70. The drop is thought to be the company’s biggest loss since November 2014, Bloomberg reports.
Continue Reading…

injection warning
February 07, 2018
Warnings against dangerous and unapproved silicone injections

Cosmetic surgery is extremely popular, with procedures being much more common and far more accessible these days. Clinicians have been keen to take on the enlarged demand, but not all are appropriately qualified, and not all are apparently using approved materials.

There are many horror stories about people trying to ‘improve’ their breasts, faces, biceps and buttocks by having all sorts of materials injected into them. In recent years, we’ve a seen a trend in silicone injections being obtained from the black market and / or being used by questionable clinicians.

The consequences can be horrifying…
Continue Reading…

mhra alert
February 05, 2018
Class 4 drug alert for Kyowa Kirin Bleo-Kyowa Powder Solution

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for the Bleo-Kyowa powder over a ‘minor’ defect being reported.

The agency cites glass particles being detected in a batch of the medicine back in April 2017.

Hospitals, pharmacies and other healthcare providers are requested to take caution in using the Bleomycin Sulphate powder that acts as an anticancer chemotherapy medicine.
Continue Reading…

e-cigarretes
February 02, 2018
Vaping and the reported health risks

A lot of people believe that using e-cigarettes instead of conventional cigarettes is much healthier because they don’t contain tar. However, vaping can still reportedly carry adverse health problems like a dry cough, throat irritation, shortness of breath and lasting implications like lung inflammation.

The chemicals used in some e-cigs are also identified as carcinogenic. So, just how safe are these alternative devices? With their growing popularity and the huge variety of flavours and tastes, from chocolate, to coffee, to fruit, is there anything to worry about? Or are the worries just diluting from the fact that they’re intended to be a suitable alternative to smoking but without the risks associated with real tobacco.
Continue Reading…

drugs alert
January 31, 2018
Ceftazidime antibiotic concentration may deteriorate if stored at the wrong temperature

The Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a medical device alert over the test disc for the antibiotic ‘Ceftazidime’, warning that storing the test discs at the wrong temperature can increase the chances of false resistance results.

The antibiotic is used to treat all sorts of bacterial infections including joint infections, sepsis, pneumonia, urinary tract infections and more. In cases where the Ceftazidime test disc was not frozen between the temperatures of +2o and -20o, notably at +8o, the antibiotic’s shelf-life may have been degraded.
Continue Reading…

fidget spinner recall
January 29, 2018
Demands for fidget spinners to be recalled over allegations of toxic lead contamination

Major retailer, Target Corporation, has recalled two of their popular fidget-spinners over reports that they contain excessive levels of toxic lead.

The heavy metal is poisonous and can cause symptoms through exposure like stomach pains, headaches, constipation, irritability, memory problems, and tingling in the hands and feet

The brain is particularly sensitive to lead exposure, and in serious cases, exposure can cause seizures, coma and even death. Survivors of lead poisoning may become anaemic and infertile
Continue Reading…

talcum-based products reportedly contained asbestos
January 26, 2018
Colgate-Palmolive settles lawsuit over its talc-based products “containing Asbestos”

Colgate-Palmolive has agreed to settle a lawsuit over claims that a claimant developed cancer after using their talcum powder products.

Carol Schoeniger reportedly developed Mesothelioma, which is a rare and fatal form of cancer that is known to be caused by asbestos exposure. This exposure allegedly came from the talc-based products she was using that reportedly contained Asbestos.

The settlement sum was not disclosed, which may have been an effort to defer others from claiming the same, but the pay-out is likely to have been significant.
Continue Reading…

baby products
January 24, 2018
80% of baby formula reportedly contains arsenic!

Scientific studies into baby food have allegedly found that a shockingly high-level of baby formulas tested contained arsenic.

To be precise, some 80%!

Arsenic poisoning is extremely serious as it can attack the blood cells and can be fatal. For a baby or an infant, the thought of them ingesting arsenic is literally horrifying. Not-for-profit organisation The Clean Label Project believes that the labelling of food and products should be completely transparent, and it was this organisation that reportedly tested a variety of baby foods, formulas, drinks and snacks for toddlers to see just what they contained.
Continue Reading…

medical device alert
January 22, 2018
Thousands of patients sue 3M for allegedly causing infections

Over 4,000 patients reportedly contracted serious infections after using 3M’s warm air blower blanket post-operation that has allegedly deposited infectious bacteria into their incisions.

Most of the patients reportedly underwent joint surgery and used the blanket to keep warm during the procedure. The deep-joint infections have reportedly caused septic arthritis in some cases. The inflammation of a joint through infection can be very painful and cause swelling, requiring treatment with anti-biotics.
Continue Reading…

January 19, 2018
Rivaroxaban recalled over rogue blister strips of reduced strength tablets

The Medicines and Healthcare Products Regulatory Authority (MHRA) has announced a recall over Xarelto 20mg film-coated tablets made by Strathclyde Pharmaceuticals Ltd. Better known as Rivaroxaban, the tablets are packaged into blister strips with the weight labelled on one side.

A batch is reportedly affected by the recall following reports of rogue blister strips carrying 15mg tablets finding their way into the twin pack 20mg tablets.

The batch number in question is BXHHDR1, due to expire in September 2019. The 28-tablet packets were reportedly first distributed on 18th September 2017.
Continue Reading…